DNLI
Denali Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
USD25.89
+0.32 (+1.25%)
Rating:C
Company Profile
CEO
Ryan J. Watts
IPO Date
2017-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$25.54
Prev. Close
$25.57
Day Low
$25.54
Day High
$26.11
52W Low
$12.58
52W High
$26.19
Market Cap
$4.11B
Volume
2.13M